Home › Funds › Royce & Associates › LRMR
Royce & Associates position in LRMR
LARIMAR THERAPEUTICS INC · Health Care
Latest position (Q3 2022)28.06K sh
Reported value held$90.00K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 28.06K | $324.00K | New |
| Q4 2021 | 28.06K | $303.00K | Hold |
| Q1 2022 | 28.06K | $114.00K | Hold |
| Q2 2022 | 28.06K | $55.00K | Hold |
| Q3 2022 | 28.06K | $90.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LRMR
- BlackRock Inc 5.68M sh · $17.32M · Q2 2026
- Vanguard Group 3.05M sh · $11.61M · Q4 2025
- AQR Capital Management 2.37M sh · $7.23M · Q2 2026
- Marshall Wace 2.01M sh · $6.14M · Q2 2026
- Geode Capital Management 1.68M sh · $5.12M · Q2 2026
- Millennium Management 1.33M sh · $4.07M · Q2 2026
- Fidelity Management & Research (FMR) 937.37K sh · $2.86M · Q2 2026
- Northern Trust Corp 550.27K sh · $1.68M · Q2 2026
- JPMorgan Chase & Co 328.01K sh · $1.05M · Q2 2026
- Renaissance Technologies 297.44K sh · $907.20K · Q2 2026
- Two Sigma Investments 236.13K sh · $720.21K · Q2 2026
- Charles Schwab Investment Management 206.97K sh · $631.25K · Q2 2026